Related Experiment Video

Updated: May 11, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

16.8K

Use of mycophenolate mofetil in new-onset systemic lupus erythematosus

Hande Ogun1, Sinem Nihal Esatoglu2

  • 1Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Istanbul, Turkey. handesaygili@gmail.com.

Clinical and Experimental Rheumatology
|April 17, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.3K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K

Related Experiment Videos

Last Updated: May 11, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

16.8K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.3K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101

Articles linked to this work by shared authors, journal, and citation graph.

Management of major organ involvement in Behçet syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations.

EULAR rheumatology open·2026

Management of mucocutaneous and joint involvement of Behçet's syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations.

EULAR rheumatology open·2026

Work productivity in Behçet syndrome.

EULAR rheumatology open·2026

Efficacy and safety of JAK inhibitors in Behçet syndrome: systematic literature review.

Seminars in arthritis and rheumatism·2026

New insights into the management of Behçet syndrome.

Expert opinion on investigational drugs·2026

Elucidating the Role of Neutrophils in the Inflammatory Response to Behcet Syndrome.

Journal of inflammation research·2026

Pathogenesis of rheumatoid arthritis: one year in review 2026.

Clinical and experimental rheumatology·2026

Domains and outcome measures for the assessment of cardiac involvement in juvenile systemic sclerosis: a scoping literature review.

Clinical and experimental rheumatology·2026

Outcome measures for cutaneous and musculoskeletal involvement in juvenile systemic sclerosis: a scoping literature review.

Clinical and experimental rheumatology·2026

Biochemical, radiological and histological effects of ixekizumab on skin tissue in a bleomycin-induced systemic sclerosis mouse model.

Clinical and experimental rheumatology·2026

Association of circulating miR-29b with microvascular dysfunction and digital ulcers in patients with systemic sclerosis: a single-centre pilot study.

Clinical and experimental rheumatology·2026

Evaluation of the gastrointestinal tract in juvenile systemic sclerosis: the paediatric gastroenterologist perspective.

Clinical and experimental rheumatology·2026

An isocaudomer-assisted AND-gate Cas12a biosensor for dual-gene identification of methicillin-resistant Staphylococcus aureus.

The Analyst·2026

BAP1 Loss in Pleural Mesothelioma Is Associated With Reduced Soluble CCL2 in Patient Effusion, Abrogated CCL2-Mediated Monocyte Recruitment In Vitro.

JTO clinical and research reports·2026

Macrolide-resistant Mycobacterium avium complex pulmonary disease: A narrative review.

Journal of clinical tuberculosis and other mycobacterial diseases·2026

Orthopaedic diagnostic pitfalls in fibroblast growth factor 23-mediated hypophosphatemic rickets/osteomalacia in fibrous dysplasia/McCune-Albright syndrome: Two burosumab-treated cases.

Bone reports·2026

Hospital burden and clinical features associated with admission among confirmed measles cases during the 2025-2026 outbreak at a tertiary care hospital in Mexico.

IJID regions·2026

Whole genome sequence data set of methicillin-resistant Staphylococcus aureus isolated from a milkman associated with cows with subclinical mastitis in Kiruhura district, Uganda.

Data in brief·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us